期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
减肥药有效性和安全性的博弈 被引量:1
1
作者 arne astrup 刘英 《中国处方药》 2010年第7期17-17,共1页
Lorcaserin的减肥作用比脂肪酶抑制剂奥司利他稍弱或者接近,但比西布曲明弱。因此决定lorcaserin能否上市的主要因素是其安全性。
关键词 安全性 有效性 减肥药 博弈 脂肪酶抑制剂 减肥作用 西布曲明
暂未订购
全球肥胖危机和体重管理的进展
2
作者 Michael E J Lean arne astrup +2 位作者 Susan B Roberts 巴天皓(译) 任倩(校) 《英国医学杂志中文版》 2021年第3期158-164,共7页
毫无疑问,食物和肥胖相关,但关系复杂。Michael Lean和他的同事探讨了有关体重管理我们已知和未知的领域。肥胖是一个未解决的危机,在全球范围内造成了长期的困扰和行动障碍,导致人力资本减少,疾病负担和医疗费用增加。肥胖的病因学很复... 毫无疑问,食物和肥胖相关,但关系复杂。Michael Lean和他的同事探讨了有关体重管理我们已知和未知的领域。肥胖是一个未解决的危机,在全球范围内造成了长期的困扰和行动障碍,导致人力资本减少,疾病负担和医疗费用增加。肥胖的病因学很复杂,在科学界和传媒界都引发了广泛争议1. 展开更多
关键词 疾病负担 体重管理 病因学 传媒界 肥胖 全球范围 行动障碍 人力资本
原文传递
Interaction of Diet/Lifestyle Intervention and TCF7L2 Genotype on Glycemic Control and Adiposity among Overweight or Obese Adults:Big Data from Seven Randomized Controlled Trials Worldwide 被引量:1
3
作者 Tao Huang Zhenhuang Zhuang +34 位作者 Yoriko Heianza Dianjianyi Sun Wenjie Ma Wenxiu Wang Meng Gao Zhe Fang Emilio Ros Liana C.Del Gobbo Jordi Salas-Salvadó Miguel A.Martínez-González Jan Polak Markku Laakso arne astrup Dominique Langin Jorg Hager Gabby Hul Torben Hansen Oluf Pedersen Jean-Michel Oppert Wim H.M.Saris Peter arner Montserrat Cofán Sujatha Rajaram Jaakko Tuomilehto Jaana Lindström Vanessa D.de Mello Alena Stancacova Matti Uusitupa Mathilde Svendstrup Thorkild I.A.Sørensen Christopher D.Gardner Joan Sabaté Dolores Corella J.Alfredo Martinez Lu Qi 《Health Data Science》 2021年第1期174-183,共10页
Objective.The strongest locus which associated with type 2 diabetes(T2D)by the common variant rs7903146 is the transcription factor 7-like 2 gene(TCF7L2).We aimed to quantify the interaction of diet/lifestyle interven... Objective.The strongest locus which associated with type 2 diabetes(T2D)by the common variant rs7903146 is the transcription factor 7-like 2 gene(TCF7L2).We aimed to quantify the interaction of diet/lifestyle interventions and the genetic effect of TCF7L2 rs7903146 on glycemic traits,body weight,or waist circumference in overweight or obese adults in several randomized controlled trials(RCTs).Methods.From October 2016 to May 2018,a large collaborative analysis was performed by pooling individualparticipant data from 7 RCTs.These RCTs reported changes in glycemic control and adiposity of the variant rs7903146 after dietary/lifestyle-related interventions in overweight or obese adults.Gene treatment interaction models which used the genetic effect encoded by the allele dose and common covariates were applicable to individual participant data in all studies.Results.In the joint analysis,a total of 7 eligible RCTs were included(n=4,114).Importantly,we observed a significant effect modification of diet/lifestyle-related interventions on the TCF7L2 variant rs7903146 and changes in fasting glucose.Compared with the control group,diet/lifestyle interventions were related to lower fasting glucose by-3.06(95%CI,-5.77 to-0.36)mg/dL(test for heterogeneity and overall effect:I^(2)=45:1%,p<0:05;z=2:20,p=0:028)per one copy of the TCF7L2 T risk allele.Furthermore,regardless of genetic risk,diet/lifestyle interventions were associated with lower waist circumference.However,there was no significant change for diet/lifestyle interventions in other glycemic control and adiposity traits per one copy of TCF7L2 risk allele.Conclusions.Our findings suggest that carrying the TCF7L2 T risk allele may have a modestly greater benefit for specific diet/lifestyle interventions to improve the control of fasting glucose in overweight or obese adults. 展开更多
关键词 TCF7L2 weight finding
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部